Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBreedon Regulatory News (BREE)

Share Price Information for Breedon (BREE)

Share Price is delayed by 15 minutes
Get Live Data
297.80    -7.60 (-2.49%)
Bid:
298.40
Ask:
299.00
Spread: 0.60 (0.201%)
Market Cap: £1.03b
BREE Live PriceLast checked at - London Stock Exchange

Intraday Breedon Share Chart

Trading Update

26 Nov 2013 07:00

RNS Number : 8712T
Breedon Aggregates Ld
26 November 2013
 



26 November 2013

 

BREEDON AGGREGATES LIMITED

("Breedon" or the "Group")

 

Trading Update & Appointment of New Group Finance Director

 

Breedon issues the following statement in advance of its year-end. The Group is due to announce its preliminary results on 4 March 2014.

 

Trading Performance

 

The Group's trading performance has been very encouraging and pre-tax profits for the full year to 31 December 2013 are expected to be somewhat ahead of market expectations, assuming favourable weather conditions for the remainder of the year. Sales volumes of aggregates, ready-mixed concrete and asphalt are all ahead year-on-year in both England and Scotland, assisted by contributions from our acquisitions of Aggregate Industries' operations in Northern Scotland and Marshalls' quarries in England.

 

Group sales revenue in the second half of the year has been stronger than in the first half and the full-year EBITDA margin is expected to be ahead of the prior year, driven by continuing improvement in the underlying business and the benefit of acquisitions.

 

Operational progress

 

Both the English and Scottish businesses continued to make good progress this year, helped by a general improvement in construction demand and a continued focus on management of costs, prudent investment and careful selection of work.

 

The Competition Commission's investigation into Breedon's acquisition of Aggregate Industries' Scottish operations is continuing and discussion regarding their findings is likely to commence in January. Breedon continues to believe that there are only minor issues in one product area, which may require disposal of a limited number of individual assets.

 

Appointment of Group Finance Director

 

The Board has been notified by Ian Peters of his intention to step down as Group Finance Director in order to pursue other interests. The Board intends to appoint Rob Wood as Ian's successor with effect from March 2014, and the required regulatory announcement will be made in due course. A Chartered Accountant, Rob, 47, is currently Group Financial Controller of Drax Group plc. He was previously Chief Financial Officer - Australia & Asia Pacific at Hanson PLC.

The Board would like to express its thanks to Ian for the significant contribution he has made to the development of the Group over the last five years and is grateful that he has agreed to remain in his role until March 2014 to ensure a smooth handover.

 

Outlook

 

For 2014 the Mineral Products Association is forecasting 2-4 per cent growth in aggregates volumes, 3-5 per cent growth in ready-mixed concrete and 2-4 per cent growth in asphalt - a more positive outlook than for a number of years. The Construction Products Association is also forecasting a return to growth in UK construction output in 2014.

 

Against this backdrop, we have reason to be optimistic about the coming year and remain confident of making further progress in 2014.

 

- ends -

 

More about Breedon Aggregates

 

Breedon Aggregates is the largest independent aggregates business in the UK after the four global majors. It operates 37 quarries, 22 asphalt plants, 48 ready-mixed concrete plants and two concrete block plants in England and Scotland and employs approximately 1,000 people.

 

The group has strong asset backing, with around 400 million tonnes of mineral reserves and resources in the UK. Breedon Aggregates' strategy is to grow through consolidation of the UK heavyside building materials sector.

 

For further information:

 

Breedon Aggregates Limited

Peter Tom CBE, Chairman

Simon Vivian, Group Chief Executive

Ian Peters, Group Finance Director

01332 694010

 

Stephen Jacobs, Head of Communications

07831 764592

 

Cenkos Securities plc (Nomad & joint broker)

Max Hartley / Nicholas Wellson 020 7397 8900

 

Peel Hunt (joint broker)

Justin Jones / Mike Bell on 020 7418 8900

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCNKPDDPBDDCDB
Date   Source Headline
17th Jul 202512:37 pmRNS-RNotice of live interactive presentation on Engage
30th Jun 20257:00 amRNSTotal Voting Rights
30th Jun 20257:00 amRNSBlock Listing Six Monthly Return
27th Jun 20254:10 pmRNSHolding(s) in Company
24th Jun 20251:00 pmRNSNotice of Interim Results
16th Jun 20254:42 pmRNSDirector/PDMR Shareholding
30th May 20259:41 amRNSTotal Voting Rights
6th May 20252:15 pmRNSHolding(s) in Company
2nd May 20253:34 pmRNSDirector/PDMR Shareholding
30th Apr 202512:46 pmRNSTotal Voting Rights
29th Apr 20254:55 pmRNSResult of AGM
29th Apr 20257:00 amRNSAGM Trading Update
17th Apr 20253:24 pmRNSHolding(s) in Company
15th Apr 20251:27 pmRNSDirector/PDMR Shareholding
15th Apr 20259:25 amRNSHolding(s) in Company
15th Apr 20259:23 amRNSHolding(s) in Company
9th Apr 20253:31 pmRNSHolding(s) in Company
8th Apr 20255:16 pmRNSDirector/PDMR Shareholding
8th Apr 20255:15 pmRNSDirector/PDMR Shareholding
31st Mar 20253:23 pmRNSTotal Voting Rights
26th Mar 20252:34 pmRNSHolding(s) in Company
17th Mar 202510:10 amRNS2024 Annual Report and Notice of AGM
12th Mar 20253:35 pmRNSApplication for Admission of Consideration Shares
7th Mar 20257:00 amRNS-RLive presentation via Investor Meet Company
6th Mar 202512:00 pmRNSCompletion of Acquisition
5th Mar 20257:01 amRNSAcquisition
5th Mar 20257:00 amRNSFinal Results
28th Feb 20251:56 pmRNSTotal Voting Rights
4th Feb 20259:25 amRNSNotice of Results
31st Jan 20257:00 amRNSTotal Voting Rights
31st Dec 20247:00 amRNSBlock listing six monthly return
31st Dec 20247:00 amRNSTotal Voting Rights
2nd Dec 20244:40 pmRNSDirector/PDMR Shareholding
29th Nov 20249:15 amRNSTotal Voting Rights
21st Nov 20247:00 amRNSNovember Trading Statement
12th Nov 20245:06 pmRNSDirector/PDMR Shareholding
31st Oct 20247:00 amRNSTotal Voting Rights
30th Sep 20241:55 pmRNSTotal Voting Rights
30th Aug 20248:49 amRNSTotal Voting Rights
31st Jul 202410:11 amRNSTotal Voting Rights
24th Jul 20247:00 amRNSInterim results 2024
11th Jul 20244:33 pmRNSHolding(s) in Company
28th Jun 20247:00 amRNSBlock listing six monthly return
28th Jun 20247:00 amRNSTotal Voting Rights
25th Jun 20242:38 pmRNSNotice of Results
13th Jun 20243:53 pmRNSDirector/PDMR Shareholding
12th Jun 20245:16 pmRNSHolding(s) in Company
12th Jun 20244:31 pmRNSDirector/PDMR Shareholding
11th Jun 20244:28 pmRNSHolding(s) in Company
6th Jun 20242:56 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.